• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白及其疾病相关突变体与微管蛋白tau有不同的相互作用,并与肌动蛋白细胞骨架相关联。

alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.

作者信息

Esposito Alessandro, Dohm Christoph P, Kermer Pawel, Bähr Mathias, Wouters Fred S

机构信息

Cell Biophysics Group at the European Neuroscience Institute-Göttingen, Waldweg, 33, 37073 Göttingen, Germany.

出版信息

Neurobiol Dis. 2007 Jun;26(3):521-31. doi: 10.1016/j.nbd.2007.01.014. Epub 2007 Feb 16.

DOI:10.1016/j.nbd.2007.01.014
PMID:17408955
Abstract

alpha-Synuclein is a primarily neuronal protein that is enriched at the pre-synapse. alpha-Synuclein and the microtubule binding protein tau have been implicated in neurodegenerative diseases. alpha-Synuclein is known to associate with phospholipid vesicles, regulates dopamine metabolism and exhibits chaperone activity, but its main role remains largely unknown. Furthermore, knowledge on its interactions and post-translational modifications is essential for a molecular understanding of alpha-synucleinopathies. We investigated alpha-synuclein mutations, causative for autosomal dominant forms of Parkinson's disease (A30P, A53T and E46K), and phosphorylation mutants at serine 129 (S129A and S129D) using fluorescently labelled alpha-synuclein, actin and tau. The investigation of colocalization, and protein-protein interactions by Förster resonance energy transfer and fluorescence lifetime imaging showed that alpha-synuclein associates with the actin cytoskeleton and interacts with tau. The A30P mutation and cytoskeletal destabilization decreased this interaction. Given the concurrent loss of membrane binding by this mutation, we propose a membrane-bound functional complex with tau that might involve the actin cytoskeleton.

摘要

α-突触核蛋白是一种主要存在于神经元中的蛋白质,在突触前富集。α-突触核蛋白和微管结合蛋白tau与神经退行性疾病有关。已知α-突触核蛋白与磷脂囊泡相关,调节多巴胺代谢并表现出伴侣活性,但其主要作用在很大程度上仍不清楚。此外,了解其相互作用和翻译后修饰对于从分子层面理解α-突触核蛋白病至关重要。我们使用荧光标记的α-突触核蛋白、肌动蛋白和tau,研究了导致常染色体显性帕金森病的α-突触核蛋白突变(A30P、A53T和E46K)以及丝氨酸129位点的磷酸化突变体(S129A和S129D)。通过Förster共振能量转移和荧光寿命成像对共定位以及蛋白质-蛋白质相互作用的研究表明,α-突触核蛋白与肌动蛋白细胞骨架相关并与tau相互作用。A30P突变和细胞骨架不稳定降低了这种相互作用。鉴于该突变同时导致膜结合丧失,我们提出一种与tau形成的膜结合功能复合物,可能涉及肌动蛋白细胞骨架。

相似文献

1
alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.α-突触核蛋白及其疾病相关突变体与微管蛋白tau有不同的相互作用,并与肌动蛋白细胞骨架相关联。
Neurobiol Dis. 2007 Jun;26(3):521-31. doi: 10.1016/j.nbd.2007.01.014. Epub 2007 Feb 16.
2
From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.从遗传学到病理学:神经退行性疾病中的tau蛋白和α-突触核蛋白聚集体
Philos Trans R Soc Lond B Biol Sci. 2001 Feb 28;356(1406):213-27. doi: 10.1098/rstb.2000.0767.
3
Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein.在过度表达A30P突变型人α-突触核蛋白的小鼠中,运动活性和诱发的多巴胺释放减少。
Neurobiol Dis. 2005 Nov;20(2):303-13. doi: 10.1016/j.nbd.2005.03.010.
4
Tau protein: relevance to Parkinson's disease.tau 蛋白:与帕金森病的关系。
Int J Biochem Cell Biol. 2010 Nov;42(11):1775-8. doi: 10.1016/j.biocel.2010.07.016. Epub 2010 Aug 1.
5
A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.一条将α-突触核蛋白与载脂蛋白E及β淀粉样肽联系起来的神经退行性变分子通路。
Nat Neurosci. 2008 Mar;11(3):301-8. doi: 10.1038/nn2058. Epub 2008 Feb 24.
6
Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.由A53Tα-突触核蛋白突变引起的家族性帕金森病中α-突触核蛋白和tau蛋白的纤维化
Exp Neurol. 2004 Jun;187(2):279-88. doi: 10.1016/j.expneurol.2004.01.007.
7
Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.神经退行性疾病中的α-突触核蛋白聚集及其抑制作为一种潜在的治疗策略。
Biochem Soc Trans. 2005 Nov;33(Pt 5):1106-10. doi: 10.1042/BST20051106.
8
Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.在帕金森病大鼠模型中,磷酸化既不会促使也不会阻止α-突触核蛋白毒性物质的形成。
Hum Mol Genet. 2009 Mar 1;18(5):872-87. doi: 10.1093/hmg/ddn417. Epub 2008 Dec 12.
9
Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.F-肌动蛋白的异常成束和积累介导了体内tau蛋白诱导的神经元变性。
Nat Cell Biol. 2007 Feb;9(2):139-48. doi: 10.1038/ncb1528. Epub 2006 Dec 24.
10
Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by alpha-synuclein oligomers.功能性蛋白激酶阵列揭示α-突触核蛋白寡聚体对p-21活化激酶4的抑制作用。
J Neurochem. 2007 Dec;103(6):2401-7. doi: 10.1111/j.1471-4159.2007.04933.x. Epub 2007 Sep 18.

引用本文的文献

1
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein.路易体痴呆:探索淀粉样β蛋白、tau蛋白和α-突触核蛋白的生物标志物及致病相互作用
Mol Neurodegener. 2025 Aug 12;20(1):90. doi: 10.1186/s13024-025-00879-0.
2
Symbiotic Bacteria: Wolbachia, Midgut Microbiota in Mosquitoes and Their Importance for Vector Prevention Strategies.共生细菌:沃尔巴克氏体、蚊子的中肠微生物群及其对病媒预防策略的重要性。
Microb Ecol. 2024 Dec 17;87(1):154. doi: 10.1007/s00248-024-02444-6.
3
Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms.
帕金森病合并症的患病率:对预后、诊断的影响及对常见致病机制的见解
J Parkinsons Dis. 2024;14(1):35-52. doi: 10.3233/JPD-230154.
4
Exploring Intra- and Inter-Regional Interactions in the IDP α-Synuclein Using smFRET and MD Simulations.使用 smFRET 和 MD 模拟探索 IDP α-突触核蛋白的内区和外区相互作用。
Biomacromolecules. 2023 Aug 14;24(8):3680-3688. doi: 10.1021/acs.biomac.3c00404. Epub 2023 Jul 5.
5
Concomitant protein pathogenesis in Parkinson's disease and perspective mechanisms.帕金森病中的伴随蛋白发病机制及潜在机制
Front Aging Neurosci. 2023 Apr 27;15:1189809. doi: 10.3389/fnagi.2023.1189809. eCollection 2023.
6
Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer's disease.α-突触核蛋白:阿尔茨海默病中的 Aβ 和 tau 病理因素及生物标志物。
Alzheimers Res Ther. 2022 Dec 31;14(1):201. doi: 10.1186/s13195-022-01150-0.
7
Biomolecular condensates can both accelerate and suppress aggregation of α-synuclein.生物分子凝聚物既能加速也能抑制α-突触核蛋白的聚集。
Sci Adv. 2022 Dec 2;8(48):eabq6495. doi: 10.1126/sciadv.abq6495.
8
Cytoskeletal dysregulation and neurodegenerative disease: Formation, monitoring, and inhibition of cofilin-actin rods.细胞骨架失调与神经退行性疾病:丝切蛋白 - 肌动蛋白杆的形成、监测及抑制
Front Cell Neurosci. 2022 Sep 22;16:982074. doi: 10.3389/fncel.2022.982074. eCollection 2022.
9
Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update.帕金森病的新兴治疗策略与未来展望:2021年更新
Biomedicines. 2022 Feb 3;10(2):371. doi: 10.3390/biomedicines10020371.
10
An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.α-突触核蛋白在帕金森病和其他突触核蛋白病中的关键作用的最新研究进展:从组织到细胞和分子水平。
Mol Neurobiol. 2022 Jan;59(1):620-642. doi: 10.1007/s12035-021-02596-3. Epub 2021 Nov 8.